Clinical Trials Browser

Phase 2 × Chondrosarcoma × pazopanib × Clear all

NCT01330966 2023-03-10

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Phase 2 Completed

47 enrolled 10 charts

Chondrosarcoma